157 related articles for article (PubMed ID: 21233249)
21. Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
Corrado G; Mancini E; Cutillo G; Baiocco E; Vici P; Sergi D; Patrizi L; Saltari M; Baffa A; Vizza E
Int J Gynecol Cancer; 2015 Sep; 25(7):1253-7. PubMed ID: 26111273
[TBL] [Abstract][Full Text] [Related]
22. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
[TBL] [Abstract][Full Text] [Related]
23. [Neoadjuvant chemotherapy and ovarian cancer].
Ray-Coquard I; Saba C; Bachelot T; Méeus P; Mignotte H; Blondet R; Treilleux I; Peix M; Guastalla JP
Bull Cancer; 2006 Jul; 93(7):669-76. PubMed ID: 16873075
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive interval cytoreductive surgery for advanced ovarian cancer.
Melamed A; Eisenhauer EL
J Surg Oncol; 2024 Jan; 129(1):126-127. PubMed ID: 38073159
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic Minimally Invasive Approach to Sentinel Lymph Node Mapping of the Ovary Using the Near-infrared Fluorescent S1 HD Pinpoint System with Indocyanine Green Dye.
Buda A; Passoni P; Reato C; Di Martino G
J Minim Invasive Gynecol; 2018 Feb; 25(2):336-337. PubMed ID: 28760628
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
27. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
[TBL] [Abstract][Full Text] [Related]
28. Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
J Gynecol Oncol; 2018 Jul; 29(4):e63. PubMed ID: 29770632
[TBL] [Abstract][Full Text] [Related]
29. Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back.
Gueli Alletti S; Vizzielli G; Lafuenti L; Costantini B; Fagotti A; Fedele C; Cianci S; Perrone E; Gallotta V; Rossitto C; Scambia G
J Minim Invasive Gynecol; 2018; 25(5):816-822. PubMed ID: 29269126
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy for ovarian cancer.
Vergote I; van Gorp T; Amant F; Neven P; Berteloot P
Oncology (Williston Park); 2005 Nov; 19(12):1615-22; discussion 1623-30. PubMed ID: 16396153
[TBL] [Abstract][Full Text] [Related]
31. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer.
Mazzeo F; Berlière M; Kerger J; Squifflet J; Duck L; D'Hondt V; Humblet Y; Donnez J; Machiels JP
Gynecol Oncol; 2003 Jul; 90(1):163-9. PubMed ID: 12821358
[TBL] [Abstract][Full Text] [Related]
33. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
[TBL] [Abstract][Full Text] [Related]
34. Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study.
Gueli Alletti S; Petrillo M; Vizzielli G; Bottoni C; Nardelli F; Costantini B; Quagliozzi L; Gallotta V; Scambia G; Fagotti A
Gynecol Oncol; 2016 Dec; 143(3):516-520. PubMed ID: 27769526
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
Timmermans M; Sonke GS; van Driel WJ; Lalisang RI; Ottevanger PB; de Kroon CD; Van de Vijver KK; van der Aa MA; Kruitwagen RF
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():98-102. PubMed ID: 29525755
[TBL] [Abstract][Full Text] [Related]
36. A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer.
Son JH; Chang K; Kong TW; Paek J; Chang SJ; Ryu HS
J Obstet Gynaecol Res; 2018 Jul; 44(7):1294-1301. PubMed ID: 29683235
[TBL] [Abstract][Full Text] [Related]
37. Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.
Gouy S; Chereau E; Custodio AS; Uzan C; Pautier P; Haie-Meder C; Duvillard P; Morice P
J Am Coll Surg; 2010 Apr; 210(4):509-14. PubMed ID: 20347745
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Morrison J; Swanton A; Collins S; Kehoe S
Cochrane Database Syst Rev; 2007 Oct; (4):CD005343. PubMed ID: 17943850
[TBL] [Abstract][Full Text] [Related]
39. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.
Gadducci A; Cosio S; Zizioli V; Notaro S; Tana R; Panattoni A; Sartori E
Int J Gynecol Cancer; 2017 Jan; 27(1):28-36. PubMed ID: 27870700
[TBL] [Abstract][Full Text] [Related]
40. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.
Rosen B; Laframboise S; Ferguson S; Dodge J; Bernardini M; Murphy J; Segev Y; Sun P; Narod SA
Gynecol Oncol; 2014 Sep; 134(3):462-7. PubMed ID: 25026637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
